Moreover, although the results of clinical studies on the prognostic value of ERG fusion detection in PCa patients remain unclear, its potential as diagnostic biomarker is evident as it is specific for prostate cancer and detectable in a non-invasive manner in the urine of patients. This evidence concerns the gene ERG and prostate cancer.